Join Chris Walsh, CEO at Acadia as he discusses how the OTC Derivatives industry is mainstreaming UMR compliance and starting to move towards optimizing their performance. Chris shares his insights on how the industry is adapting to a more holistic approach to risk, margin and collateral -coining the phrase Optimal Margin Management.
Recorded and produced by Lansons
Listen time – 13 minutes
In Episode 19 of Ahead of the Curve, Will Thomey and Richard Barton from Acadia discuss the merits of improving efficiency and fully automating...
Join us for a special extended episode of Ahead of the Curve as we sit down with derivative market leaders Scott O’Malia CEO of...
In this Episode of Ahead of the Curve, John Pucciarelli – Head of Industry & Regulatory Strategy at AcadiaSoft is joined by guest speaker...